with gastrointestinal disorders being the most common reason for discontinuation.Conclusions Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater reductions in body weight and pain related to kne...
Once-weekly insulin for type 2 diabetes without previous insulin treatment. N Engl J Med. 2020;383(22):2107-2116. doi:10.1056/NEJMoa2022474PubMedGoogle ScholarCrossref 7. Philis-Tsimikas A, Bajaj HS, Begtrup K, et al. Rationale and design of the phase 3a development ...
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2017;377:1228-1239. doi: 10.1056/NEJMoa1612917.Holman RR, Bethel MA, Mentz RJ, et al. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2017;377:...